Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

UDP Glucuronosyltransferases Inhibitors [MoA]

Known as: UDP Glucuronosyltransferases (UGT) Inhibitors, UDP Glucuronosyltransferases Inhibitors, UGT Inhibitors 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Quantitative proteomic methods require optimization at several stages, including sample preparation, liquid chromatography–tandem… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2017
Review
2017
Bladder cancer has been linked to numerous toxins which can be concentrated in the bladder after being absorbed into the blood… Expand
  • figure 1
  • figure 2
  • figure 3
2017
2017
INDONESIA: Pembiayaan rahn tasjily merupakan produk yang banyak digunakan anggota serta belum memiliki standar akuntansi yang… Expand
2016
2016
Koperasi Baitul Maal Wattamwil (BMT) merupakan salah satu lembaga yang menggunakan landasan syariah yaitu segala ketentuannya… Expand
2014
2014
The impact of the intestine in determining the oral bioavailability of drugs has been extensively studied. Its large surface area… Expand
  • figure 1-1
  • table 1-1
  • table 1-2
  • figure 1-2
  • figure 1-3
Highly Cited
2009
Highly Cited
2009
Previous studies demonstrated that perinatal exposure to polybrominated diphenyl ethers (PBDEs), a major class of brominated… Expand
Review
2008
Review
2008
The substrate spectrum of human UDP-glucuronosyltransferase 1A (UGT1A) proteins includes the glucuronidation of non-steroidal… Expand
2004
2004
The dose-response relationship for antiepileptic drugs (AEDs) varies enormously between and within individual patients… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4